Showing results (11-20 of 108) with videos related to
Sort By:
Pageof 11
Expert Review of Hematology|October 26, 2023
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia BGiancarlo Castaman, Michiel Coppens, Steven W PipeExpert Opinion on Biological Therapy|June 16, 2022
Challenges and opportunities when transitioning from <i>in vivo</i> gene replacement to <i>in vivo</i> CRISPR/Cas9 therapies - a spotlight on hemophiliaOscar G Segurado, Ruhong Jiang, Steven W PipeExpert Review of Hematology|August 21, 2023
Efficacy and safety evaluation of eptacog beta (coagulation factor VIIa [recombinant]-jncw) for the treatment of hemophilia A and B with inhibitorsSteven W Pipe, Amy L Dunn, Guy YoungHaemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2022
Gene therapy: Practical aspects of implementationSteven W Pipe, K Rajender Reddy, Pratima ChowdaryBlood|May 18, 2018
Novel therapeutics for hemophilia and other bleeding disordersMichael U Callaghan, Robert Sidonio, Steven W PipeLancet (London, England)|March 1, 2025
HaemophiliaPratima Chowdary, Manuel Carcao, Gili Kenet, et al.Journal of Thrombosis and Haemostasis : JTH|December 17, 2020
Mortality in congenital hemophilia A - a systematic literature reviewCharles R M Hay, Francis Nissen, Steven W PipeExpert Opinion on Biological Therapy|November 16, 2021
Hemophilia A gene therapy: current and next-generation approachesSteven W Pipe, Gil Gonen-Yaacovi, Oscar G SeguradoLancet (London, England)|January 18, 2021
The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editingMaria Elisa Mancuso, Johnny N Mahlangu, Steven W PipeJournal of Perinatology : Official Journal of the California Perinatal Association|March 16, 2002
Neonatal sinovenous thrombosis associated with homozygous thermolabile methylenetetrahydrofolate reductase in both mother and infantJennifer L Grow, Paola J Fliman, Steven W PipePageof 11